Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial - Cadegiani, F A; McCoy, J; Gustavo Wambier, C (Cureus, 2021)
et al.